Aim: Lupus nephritis (LN) is one of the most serious complications of SLE. Tregs (Regulatory T lymphocytes) are thought to play a part in the pathogenesis of SLE. According to recent research, Foxp3, a Treg identification marker, plays a significant role in the pathogenesis of SLE. This study aimed to compare the urinary Foxp3 mRNA levels of patients with active and inactive forms of LN and healthy control subjects to see whether it played a role in disease activity.

Methods: We measured FOXP3 messenger RNA (mRNA) expression in the urine of 50 people with active LN, 50 people with inactive lupus, and 50 healthy people.

Results: We found that the expression level of FOXP3 was significantly higher in urine from patients with active LN than from subjects with inactive lupus and healthy controls (22.93 ± 4.13 vs 5.66 ± 0.47 vs 0.57 ± 0.15copy; P < 0.001).Urinary FOXP3 mRNA level significantly correlated with SLEDAI (0.000057) In the active group, urinary FOXP3 mRNA level also significantly correlated with histological activity index (< 0.00001).

Conclusion: We concluded that urinary FOXP3 mRNA is elevated in patients with active LN and that it is linked to the SLEDAI and the severity of the disease. FOXP3 mRNA in urine sediment may be used as a non-invasive biomarker for evaluating the severity of LN and risk stratification.

Download full-text PDF

Source
http://dx.doi.org/10.1177/09612033211030559DOI Listing

Publication Analysis

Top Keywords

urinary foxp3
8
foxp3 mrna
8
lupus nephritis
8
pathogenesis sle
8
patients active
8
inactive lupus
8
lupus healthy
8
foxp3
5
lupus
5
evaluation urinary
4

Similar Publications

Injectable Genetic Engineering Hydrogel for Promoting Spatial Tolerance of Transplanted Kidney in Situ.

Adv Sci (Weinh)

December 2024

Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Key Laboratory of Kidney Disease Prevention and Control Technology, National Key Clinical Department of Kidney Diseases, Institute of Nephrology, Zhejiang University, Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, Zhejiang, 310003, P. R. China.

The establishment of a tolerant space to realize the co-stimulation of cytokines and contact-dependent molecules remain challenging in allotransplant. Here, an injectable genetically engineered hydrogel (iGE-Gel) is reported, which developed with a multivalent network of FOXP3 engineered extracellular vesicles (Foe-EVs) through the hydrophobic interaction between stearic acid modified hyaluronic acid (HASA) and the membrane phospholipids of extracellular vesicles (EVs). The iGE-Gel exhibited self-healing properties, injectability and biocompatibility.

View Article and Find Full Text PDF

Non-muscle-invasive bladder cancer (NMIBC) presents management challenges due to its high recurrence rate and a complex tumor microenvironment (TME). This study investigated the effects of OncoTherad® (MRB-CFI1) nanoimmunotherapy on the TME of BCG-unresponsive NMIBC, focusing on alterations in monoamine oxidases (MAO-A and MAO-B) and immune markers: CD163, FOXP3, CD8, and CX3CR1. A comparative analysis of immunoreactivities was made before and after OncoTherad® treatment and an immune score (IS) was established to evaluate the correlation between immunological changes and clinical outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied the immune activity in bladder cancer (BC) by analyzing 159 samples and categorizing them into two groups: a "hot cluster" with high immune marker expression and a "cold cluster" with low expression.
  • High-grade T1 tumors were often found in the hot cluster, indicating active immune responses, while tumors that progressed to muscle invasion were generally in the cold cluster, correlating with a higher risk of disease progression.
  • The study identified key molecular alterations between the hot and cold clusters and emphasized the importance of maintaining immune activity after BCG therapy for recurrent non-muscle-invasive bladder cancer (NMIBC), suggesting new treatment targets.
View Article and Find Full Text PDF

Revised version with tracked changes oral Magnesium reduces levels of pathogenic autoantibodies and skin disease in murine lupus.

BMC Immunol

September 2024

Precision Immunology Institute, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1243, New York, NY, 10029, USA.

Article Synopsis
  • Systemic Lupus Erythematosus (SLE) is linked to genetic factors, but the role of diet, specifically magnesium (Mg), in influencing disease severity is not well understood.
  • A study involving lupus-prone mice showed that a high Mg diet led to fewer skin lesions, milder histological damage, and lower levels of harmful antibodies compared to a normal diet.
  • The findings suggest that increasing Mg intake could have a protective effect in lupus, making it a potentially beneficial and cost-effective addition to treatment strategies.
View Article and Find Full Text PDF

Follicular helper and regulatory T cells (Tfh/TFR) cells are distinct subsets of CD4 cells that have been recognized for their critical role in regulating cellular reactions within the germinal centers of lymphoid follicles. In the present study, we aimed to determine the presence and the frequency of these cells in draining lymph nodes of patients with bladder cancer (BC). Forty-six patients with BC who had undergone radical cystectomy and pelvic lymph node dissection were enrolled.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!